De Giorgi R, Ghenciulescu A, Yotter C et al (2025) Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders
It is thought to benefit the entire gastrointestinal tract, as well as playing a positive role following strokes, schizophrenia, and spinal cord injuries [9]
Carnitine for Kidney Disease and Hemodialysis Given that the kidney is a major site of carnitine production, damage to this organ can cause a significant carnitine deficiency
Comparison and Clinical Implications Final Verdict: Platelet-Rich Plasma is a Validated Treatment, While Peptide Therapy Requires Further Research While peptide injections show promise in preclinical studies, their role in musculoskeletal treatment remains experimental , with a lack of well-controlled human trials to confirm their efficacy
Furthermore, research by Zhang et al
Kudoh Y, Shoji T, Oimatsu H, Yoshida S, Kikuchi K, Iimura O (1983) The role of L-carnitine in the pathogenesis of cardiomegaly in patients with chronic hemodialysis